Please use this identifier to cite or link to this item:
Title: The delivery of BCNU to brain tumors
Authors: Wang, C.-H. 
Li, J.
Teo, C.S.
Lee, T.
Keywords: 1-3-Bis(2-chloroethyl)-1-nitrosourea
Polymeric delivery
Systemic administration
Issue Date: 27-Aug-1999
Citation: Wang, C.-H., Li, J., Teo, C.S., Lee, T. (1999-08-27). The delivery of BCNU to brain tumors. Journal of Controlled Release 61 (1-2) : 21-41. ScholarBank@NUS Repository.
Abstract: This paper reports the development of three-dimensional simulations to study the effect of various factors on the delivery of 1-3-bis(2-chloroethyl)-1-nitrosourea (BCNU) to brain tumors. The study yields information on the efficacy of various delivery methods, and the optimal location of polymer implantation. Two types of drug deliveries, namely, systemic administration and controlled release from polymers, were simulated using fluid dynamics analysis package (FIDAP) to predict the temporal and spatial variation of drug distribution. Polymer-based delivery provides higher mean concentration, longer BCNU exposure time and reduced systemic toxicity than bolus injection. Polymer implanted in the core gives higher concentration of drug in both the core and viable zone than the polymer in the viable zone case. The penetration depth of BCNU is very short. This is because BCNU can get drained out of the system before diffusing to any appreciable distance. Since transvascular permeation is the dominant means of BCNU delivery, the interstitial convection has minor effect because of the extremely small transvascular Peclet number. The reaction of BCNU with brain tissues reduces the drug concentration in all regions and its effect increases with rate constant. The implantation of BCNU/ethylene-vinyl acetate copolymer (EVAc) matrix at the lumen of the viable zone immediately following the surgical removal of 80% of the tumor may be an effective treatment for the chemotherapy of brain tumors. The present study provides a quantitative examination on the working principle of Gliadel(®) wafer for the treatment of brain tumors. Copyright (C) 1999 Elsevier Science B.V.
Source Title: Journal of Controlled Release
ISSN: 01683659
DOI: 10.1016/S0168-3659(99)00098-X
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.


checked on Feb 20, 2019


checked on Feb 4, 2019

Page view(s)

checked on Nov 24, 2018

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.